Arsenic species directly modulate several oncogenic pathways - most notably the EGFR, PI3K/AKT and the NRF2/KEAP1 pathways - and these specific pathways possess actionable targets for therapy in lung cancer. Here, PIK3CG is linked to lung carcinoma.